Clinical Trial Update: Safety Study of P28GST Treatment in Crohn's Disease Patients [Phase 2]

View source ↗

Summary

A Phase 2 safety study of P28GST in Crohn's disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• P28GST

Snippet

Sponsor: University Hospital, Lille | Conditions: Crohn's Ileocolitis | Phase 2 | Status: COMPLETED